TXG Annual Total Debt
$95.37 M
+$194.00 K+0.20%
31 December 2023
Summary:
As of January 20, 2025, TXG annual total debt is $95.37 million, with the most recent change of +$194.00 thousand (+0.20%) on December 31, 2023. During the last 3 years, it has risen by +$32.39 million (+51.43%). TXG annual total debt is now at all-time high.TXG Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Quarterly Total Debt
$85.88 M
-$3.61 M-4.03%
30 September 2024
Summary:
As of January 20, 2025, TXG quarterly total debt is $85.88 million, with the most recent change of -$3.61 million (-4.03%) on September 30, 2024. Over the past year, it has dropped by -$12.60 million (-12.79%). TXG quarterly total debt is now -97.13% below its all-time high of $3.00 billion, reached on September 1, 2017.TXG Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.2% | -12.8% |
| 3 y3 years | +51.4% | +4.8% |
| 5 y5 years | +221.4% | +189.0% |
TXG Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.3% | -15.8% | +4.8% |
| 5 y | 5-year | at high | +220.9% | -15.8% | +189.0% |
| alltime | all time | at high | +803.2% | -97.1% |
10x Genomics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $85.88 M(-4.0%) |
| June 2024 | - | $89.48 M(-2.9%) |
| Mar 2024 | - | $92.18 M(-3.3%) |
| Dec 2023 | $95.37 M(+0.2%) | $95.37 M(-3.2%) |
| Sept 2023 | - | $98.47 M(-1.1%) |
| June 2023 | - | $99.62 M(-2.4%) |
| Mar 2023 | - | $102.04 M(+7.2%) |
| Dec 2022 | $95.18 M(+16.1%) | $95.18 M(-1.1%) |
| Sept 2022 | - | $96.23 M(-2.8%) |
| June 2022 | - | $99.02 M(-2.1%) |
| Mar 2022 | - | $101.17 M(+23.4%) |
| Dec 2021 | $81.98 M(+30.2%) | $81.98 M(+2.2%) |
| Sept 2021 | - | $80.20 M(+13.2%) |
| June 2021 | - | $70.82 M(-2.3%) |
| Mar 2021 | - | $72.50 M(+15.1%) |
| Dec 2020 | $62.98 M(+111.9%) | $62.98 M(+2.2%) |
| Sept 2020 | - | $61.59 M(+4.1%) |
| June 2020 | - | $59.17 M(-0.8%) |
| Mar 2020 | - | $59.62 M(+100.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $29.72 M(+0.1%) | $29.72 M(+0.1%) |
| Sept 2019 | - | $29.69 M(+0.1%) |
| June 2019 | - | $29.66 M(>+9900.0%) |
| Mar 2019 | - | $0.00(-100.0%) |
| Dec 2018 | $29.68 M(+181.0%) | $29.68 M(>+9900.0%) |
| Sept 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $10.56 M | - |
| Sept 2017 | - | $3.00 B(+20.2%) |
| June 2017 | - | $2.49 B(+3.4%) |
| Mar 2017 | - | $2.41 B(+11.9%) |
| Dec 2016 | - | $2.15 B(-3.1%) |
| Sept 2016 | - | $2.22 B(+0.1%) |
| June 2016 | - | $2.22 B(-5.4%) |
| Mar 2016 | - | $2.35 B(+12.4%) |
| Dec 2015 | - | $2.09 B(-4.8%) |
| Sept 2015 | - | $2.20 B(+3.5%) |
| June 2015 | - | $2.12 B(-0.6%) |
| Mar 2015 | - | $2.14 B(-7.5%) |
| Dec 2014 | - | $2.31 B |
FAQ
- What is 10x Genomics annual total debt?
- What is the all time high annual total debt for 10x Genomics?
- What is 10x Genomics annual total debt year-on-year change?
- What is 10x Genomics quarterly total debt?
- What is the all time high quarterly total debt for 10x Genomics?
- What is 10x Genomics quarterly total debt year-on-year change?
What is 10x Genomics annual total debt?
The current annual total debt of TXG is $95.37 M
What is the all time high annual total debt for 10x Genomics?
10x Genomics all-time high annual total debt is $95.37 M
What is 10x Genomics annual total debt year-on-year change?
Over the past year, TXG annual total debt has changed by +$194.00 K (+0.20%)
What is 10x Genomics quarterly total debt?
The current quarterly total debt of TXG is $85.88 M
What is the all time high quarterly total debt for 10x Genomics?
10x Genomics all-time high quarterly total debt is $3.00 B
What is 10x Genomics quarterly total debt year-on-year change?
Over the past year, TXG quarterly total debt has changed by -$12.60 M (-12.79%)